Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Pituitary tumor
Trial Status:  Active
Results 1-25 of 45 for your search:
Start Over
Characterization of Receptors in Non-functioning Pituitary Macroadenomas
Phase: Phase IV
Type: Biomarker/Laboratory analysis
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 06-044, NCT00852501
Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in a Novartis-sponsored Study.
Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CSOM230B2412, NCT01794793
A Pilot Study of Pre- and Post-operative Use of Somatuline Depot.
Phase: Phase IV
Type: Supportive care
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: KELD-ESS-0413, NCT01861717
Effect of Perioperative Glucocorticoid Replacement on Prognosis of Surgical Patients With Sellar Lesions
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: WestChina-2013137, NCT02190994
Analgesia Regimens Following Trans-sphenoidal Surgery for Pituitary Tumors
Phase: Phase IV
Type: Health services research, Supportive care
Status: Active
Age: 18 to 79
Sponsor: Other
Protocol IDs: 14BN090, NCT02351700
Expression Profile of Somatostatin Receptors and Dopamine Receptor 2 in Non-functioning Pituitary Adenomas and Resistant Prolactinomas: Correlation With in Vivo Response to Pasireotide and Cabergoline
Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CSOM230BBR01T, NCT01620138
Managing Cancer and Living Meaningfully (CALM): A Study to Evaluate the Effectiveness of a Psychological Intervention for Cancer Patients
Phase: Phase III
Type: Educational/Counseling/Training, Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: UHN REB 09-0855-C, CIHR, NCT01506492
An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CSOM230B2406, NCT01582061
90Yttrium Colloid for the Treatment of Cystic Sellar/Parasellar Tumors
Phase: Phase III
Type: Treatment
Status: Active
Age: 17 and over
Sponsor: Other
Protocol IDs: Yttrium2014, NCT02081768
Dopamine Agonist Treatment of Non-functioning Pituitary Adenomas (NFPAs) - a Randomized Controlled Trial
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: 2012/677, 2012-001338-32, NCT02288962
Ga-68-DOTATOC -PET in the Management of Pituitary Tumours
Phase: Phase III
Type: Biomarker/Laboratory analysis, Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: Ga-PET version 8 (141017), 2010-020482-24, NCT02419664
Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers
Phase: Phase II, Phase I
Type: Tissue collection/Repository
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: 93-102, NCT00579163
Targeted Therapy With Lapatinib in Patients With Recurrent Pituitary Tumors Resistant to Standard Therapy
Phase: Phase II
Type: Treatment
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: 18129, NCT00939523
Antineoplaston Therapy in Treating Patients With Brain Tumors
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000066489, BC-BT-9, NCT00003457
Evaluate the Efficacy and Safety of Pasireotide LAR on the Treatment of Patients With Clinically Non-Functioning Pituitary Adenoma
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CSOM230D2401, NCT01283542
Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CSOM230B2411, NCT01915303
Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 140021, 14-C-0021, NCT02001051
Evaluation of Patients With Thyroid Disorders
Phase: No phase specified
Type: Natural history/Epidemiology
Status: Active
Age: Any age
Sponsor: NIDDK
Protocol IDs: 770002, 77-DK-0002, NCT00001159
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
Phase: No phase specified
Type: Genetics, Health services research
Status: Active
Age: 3 to 70 OR any age (family members)
Sponsor: NICHD
Protocol IDs: 970076, 97-CH-0076, NCT00001595
Evaluation and Treatment of Neurosurgical Disorders
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 4 to 120
Sponsor: NINDS
Protocol IDs: 030164, 03-N-0164, NCT00060541
Prevalence of Pituitary Incidentaloma in Relatives of Patients With Pituitary Adenoma
Phase: No phase specified
Type: Biomarker/Laboratory analysis
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 3765, NCT00598949
Pituitary Tumor Surveillance: Pathogenic Correlation
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2873, NCT00599092
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA
Phase: No phase specified
Type: Biomarker/Laboratory analysis
Status: Active
Age: 6 and over
Sponsor: Other
Protocol IDs: 004842, NCT00461188
Proton Radiation Therapy for Pituitary Adenoma
Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: UFPTI 0701-PI01, NCT00798057
Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
Phase: No phase specified
Type: Biomarker/Laboratory analysis
Status: Active
Age: 7 and over
Sponsor: NCI
Protocol IDs: 090242, 09-C-0242, NCT01005654
Start Over